Luigi Aurisicchio, CEO of Takis, and Lucio Rovati, CEO of Rottapharm biotech, interviewed on the journal of SIMeF – Società Italiana di Medicina Farmaceutica.  

They talked about the contribution of Italian research to the race for a vaccine against Sars-Cov-2 and pointed out the strengths and critical issues of the vaccines under study, their production and clinical experimentation .

Italy is among the leading countries in the development of a vaccine. We believe that investments in innovation are fundamental engine of the economic growth of a developed country.

 

Read the interview here

or click on image

  • Terms of use
  • Privacy
  • Ethical code
  • This email address is being protected from spambots. You need JavaScript enabled to view it.
  • Webmail